GCM
OFIX icon

Gladius Capital Management’s Orthofix Medical OFIX Stock Holding History

Gladius Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,841
Closed -$38.3K – 389
2023
Q4 		$38.3K Buy
2,841
+1,010
+55% +$11.9K 0.01% 218
2023
Q3 		$23.5K Buy
1,831
+568
+45% +$10.2K ﹤0.01% 332
2023
Q2 		$22.8K Sell
1,263
-470
-27% -$8.78K ﹤0.01% 294
2023
Q1 		$29K Sell
1,733
-285
-14% -$5.58K ﹤0.01% 290
2022
Q4 		$41.4K Buy
2,018
+108
+6% +$1.91K ﹤0.01% 209
2022
Q3 		$37K Buy
+1,910
New +$42.9K ﹤0.01% 235

Other funds holding OFIX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $428M AUM 136.02% 1-Year Est. Return

Gladius Capital Management's OFIX Position: Q1 2024 in Review

Gladius Capital Management sold out of Orthofix Medical (OFIX) in Q1 2024, closing a stake of 2,841 shares — an estimated $38.3K sold.

Gladius Capital Management first reported a position in OFIX in Q3 2022 and held it in 6 quarters. The position peaked at $41.4K in Q4 2022. 136 funds tracked by Wall St. Rank hold OFIX as of Q1 2024.

  • Gladius Capital Management reported no remaining Orthofix Medical position as of Q1 2024 after selling out during the quarter.
  • Gladius Capital Management sold 2,841 Orthofix Medical shares in Q1 2024, an estimated $38.3K.
  • Gladius Capital Management first reported a position in Orthofix Medical in Q3 2022 and held it in 6 quarters.
  • Gladius Capital Management's Orthofix Medical position peaked at $41.4K in Q4 2022.
  • 136 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2024.

Based on Gladius Capital Management's 13F filing for Q1 2024, filed 14 May 2024.